Monday, December 9, 2024

CATEGORY

Chugai Pharmaceutical

Rituxan Gains Approval for Pediatric Chronic ITP Treatment in Japan

Chugai Pharmaceutical Co., Ltd. and Zenyaku Kogyo Co., Ltd. have secured approval from Japan’s Ministry of Health, Labour and Welfare for the use of...

Latest news